PMID: 6751905Sep 1, 1982Paper

Immunohistochemical identification of factor X-like antigen in the A cells of the normal human pancreas

C BetterleA Girolami


An indirect immunofluorescence technique using two rabbit anti-human factor X sera was used to investigate the presence of factor X in various human tissues. Of all tissues studied only the cytoplasm of some islet cells of the six human pancreases illustrated specific reactivity for factor X-like material. No reaction was seen in the exocrine pancreas. Cross-absorption studies with factor X-deficient plasma, glucagon or alpha-1-antitrypsin did not modify the pattern. On the contrary, cross-absorption with factor X Friuli or with normal plasma eliminated the positivity. No factor X-like material was seen in rat or guinea pig pancreas. The double-immunofluorescence technique demonstrated that the reactivity was localized only in the cytoplasm of the A cells.


Dec 13, 1978·Histochemistry·J AlumetsF Sundler
Jan 1, 1977·Annual Review of Medicine·R H Unger, L Orci
Nov 30, 1977·Cell and Tissue Research·M B RayW Gepts
May 1, 1978·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·G F Del PreteG Bersani
Dec 28, 1978·Histochemistry·D GrubeE Weber
Oct 20, 1979·British Medical Journal·J H FullerY Stirling
Jan 1, 1975·Acta Haematologica·A GirolamiO Prinoth
Jun 14, 1969·Lancet·J BrostoffD Doniach
Apr 1, 1969·Vox Sanguinis·I M Roitt
Nov 1, 1973·The Journal of Clinical Investigation·L W HoyerJ R Hoyer
Apr 1, 1970·The Journal of Clinical Investigation·R H UngerA M Eisentraut
Aug 19, 1971·The New England Journal of Medicine·R H Unger
Sep 1, 1969·The American Journal of Physiology·W J Dodds
May 1, 1966·The Journal of Clinical Investigation·J P OlsonS B Troup
Jun 18, 1981·The New England Journal of Medicine·R H Unger, L Orci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.